Tempus Stock

tempus.comHealthcareFounded: 2015Funding to Date: $818.33MM

Tempus is a biotechnology company focused on making precision medicine a reality by applying AI in healthcare, deriving insights from an expansive library of clinical data and molecular data.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Tempus, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Eric Lefkofsky
Founder & Chief Executive Officer
Kevin White, Ph.D.
Chief Science Officer
Gary Palmer, MD
Chief Medical Officer
Ryan Fukushima
Chief Operating Officer
Shane Colley
Chief Technology Officer
Mike Yasiejko
Chief Commercial Officer
Vanessa Rollings
Chief Financial Officer
Marc Yoskowitz
Chief Strategy Officer
Chief Strategy Officer
Chief People Officer

Board Members

David Agus, MD
Arul M. Chinnaiyan, MD, Ph.D.
Funmi Olopade, MD
Eric Topol, MD
A. Keith Stewart, MB.CHB., MBA
Peter Barris
New Enterprise Associates
Steve Case
Revolution
John Doerr
Kleiner Perkins

Other companies like Tempus in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$263MM
Sector
Last Round Est. Valuation
$67.5MM

News

Groupon co-founder Eric Lefkofsky started Tempus in September 2015. This round comes comes less than 10 months after the startup raised $200 million.
TangoTrade, a financial software provider that empowers small and medium-sized businesses (SMBs) to import and export globally, announced today the launch of its Payment AssuranceTM solution with Tempus, a leading foreign exchange (FX) and international payment solutions company.